Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven J Frank
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, United States
- Willis-Knighton Medical and Cancer Center
Shreveport, Louisiana, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- New York Proton Center
New York, New York, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- University of Pennsylvania/abramson Cancer Center
Philadelphia, Pennsylvania, United States
- Md Anderson in the Woodlands
Conroe, Texas, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Md Anderson West Houston
Houston, Texas, United States
- Md Anderson League City
League City, Texas, United States
- Md Anderson in Sugar Land
Sugar Land, Texas, United States
- Inova Schar Cancer Institute
Fairfax, Virginia, United States
- Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2013
- Primary completion
- 31 Dec 2031
- Completion
- 31 Dec 2031
- Last update posted
- 24 Feb 2026
- Registered enrollment
- 440
- Registry id
- NCT01893307
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.